Phase 2 trial of trastuzumab (T) and KOS-953 (17-AAG) in patients (pts) with Her2-positive breast cancer: Preliminary results Meeting Abstract

  


Authors: Modi, S.; Stopeck, A.; Linden, H. M.; Sugarman, S.; Ma, W.; Solit, D.; Rosen, N.; Kersey, K.; Johnson, R. G.; Hannah, A. L.; Hudis, C.
Abstract Title: Phase 2 trial of trastuzumab (T) and KOS-953 (17-AAG) in patients (pts) with Her2-positive breast cancer: Preliminary results
Meeting Title: 29th Annual San Antonio Breast Cancer Symposium (SABCS)
Journal Title: Breast Cancer Research and Treatment
Volume: 100
Issue: Suppl. 1
Meeting Dates: 2006 Dec 14-17
Meeting Location: San Antonio, TX
ISSN: 0167-6806
Publisher: Springer  
Date Published: 2006-12-01
Start Page: S72
Language: English
ACCESSION: WOS:000242047100206
PROVIDER: wos
PUBMED: 17187236
DOI: 10.1007/s10549-006-5678-0
Notes: --- - Meeting Abstract: 1102 - 29th Annual San Antonio Breast Cancer Symposium - DEC 14-17, 2006 - San Antonio, TX - "1" - "Source: Wos"
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Clifford Hudis
    905 Hudis
  2. Neal Rosen
    425 Rosen
  3. David Solit
    781 Solit
  4. Steven M Sugarman
    39 Sugarman
  5. Shanu Modi
    268 Modi
Related MSK Work